The brain is dependent on glucose as a primary energy substrate, but is capable of utilizing ketones such as b-hydroxybutyrate and acetoacetate, as occurs with fasting, starvation, or chronic feeding of a ketogenic diet. The relationship between changes in cerebral metabolic rates of glucose (CMR glc ) and degree or duration of ketosis remains uncertain. To investigate if CMR glc decreases with chronic ketosis, 2-[
INTRODUCTION
Researchers and clinicians have been interested in brain metabolism during starvation, fasting, or acute ketosis for many decades. Under physiologic blood glucose concentrations, the fractional contribution of ketone bodies to oxidative metabolism in adult brain has remained uncertain. During prolonged starvation, brain energy requirements have been traditionally accepted to be supplemented by ketone body oxidation. 1, 2 The conviction was founded on the rationale that under glucose-sparing conditions, a large portion of oxidative energy must be derived from ketone bodies and thus resulting in reduced glucose consumption. [1] [2] [3] Historically, there has been controversy among researchers whether there is a causal relationship between changes in CMR glc with degree and duration of ketosis. The inconsistencies across studies were revealed when the effects of short-term fasting (or acute ketosis) on changes in CMR glc were further explored. [3] [4] [5] [6] [7] We deem that ketones are effective against pathology associated with altered glucose metabolism and inadequate regulation of salvation pathways. We hypothesize that ketone bodies are neuroprotective through the restoration in energy balance via suppression of glucose oxidation and stabilization of ATP supply. Ketone bodies, such as b-hydroxybutyrate (BHB) and acetoacetate (AcAc), are alternative energy substrates to glucose especially important during development and glucose-sparing conditions, such as with fasting, starvation, and diet-induced ketosis. 1, [8] [9] [10] [11] The relationship between energy supply and demand and the partitioning of substrate utilization between glucose and ketones in brain continues to be explored. The ketogenic diet (high-fat, very low-carbohydrate) to induce chronic ketosis has been successfully used in the clinical setting as a therapy for intractable seizures for nearly a century. 9, [12] [13] [14] [15] However, the 'mechanistic link' between the anticonvulsant effects and ketosis continues to be investigated and remains to be elucidated. 16 Ketone bodies as neuroprotective agents appear to be related to the change in the regulation of the cell's stress responses, 17 as well as changes in oxidative (glucose) metabolism. 18, 19 Neuroprotection by ketosis is thought to be associated with improved mitochondrial function, decreased reactive oxygen species, apoptotic and inflammatory mediators, and protective pathways. 9, 20 In the last few decades, the 2-deoxy-D-glucose or positron emission tomography (PET) approaches have been applied to ketotic studies, in both animal, 18, [21] [22] [23] and humans. 2, 5, 24, 25 Reports of altered CMR glc as a result of short-term fasting [3] [4] [5] [6] [7] or acute infusions of ketone bodies 25, 26 had generated discrepancies. What remained to be clarified was (i) whether oxidation of ketone bodies can replace glucose proportionately during acute/mild ketosis under normoglycemia and (ii) the percent of glucose sparing with degree of ketosis. Some studies reported generalized, decreasing CMR glc with 3 to 5 days of fasting in humans 2, 5, 24 while in other studies, there were no significant changes in CMR glc . 3, 21, 27, 28 The goal of this study was to estimate CMR glc in chronic ketotic rats and to determine if ketosis induces a metabolic adaptation through changes in glucose phosphorylation rates. The effects of ketosis on CMR glc in intact brain during stabilized blood glucose conditions in diet-induced ketotic rats using PET and 2-[ ) were determined. The rationale for using PET-FDG was based on the principle that the phosphorylation rate of 18 FDG (a trapping tracer) can be used to estimate the phosphorylation rate of glucose. In support of our findings, a retrospective analysis of historical data (meta-analysis) to resolve the inconsistencies across studies was also performed.
MATERIALS AND METHODS

Animal Model and Diets
Young adult male Wistar rats were purchased from Charles River (Wilmington, MA, USA), 40 days old, and weighing B150 grams. All procedures were performed in strict accordance with the National Institutes of Health Guide for Care and were approved by Institutional Animal Care and Use Committee of Case Western Reserve University. Body weights were measured upon arrival and on the experimental day (Table 1) . Littermates were housed three per cage in the Case Western Reserve University Animal Resource Center with 12:12 hours light/dark cycle. All rats were allowed to acclimate for 1 week before initiating dietary protocols. Standard rodent diet (STD) was fed to all rats during the acclimation period (Cincinnati Lab Supply, Cincinnati, OH, USA, Labdiet Prolab RMH3000 ANE) ad libitum. One week after their arrival, all rats were fasted overnight for 16 hours to deplete the liver glycogen stores and initiate ketosis. Rats were then randomly assigned to two diets, STD or ketogenic diet (ketogenic, KG; Research Diet, New Brunswick, NJ, USA, D12369b) and fed for 3 weeks ad libitum until FDG-PET experiments. 29 The macro and micronutrient of the STD and KG diets is shown in Supplementary material 1. The original datasheets for the diets are included in Supplementary material 2 and 3.
Anesthesia and Surgery
On the experimental day (post 3 weeks of diets) rats were morning fasted for 6 hours before PET imaging. Rats were then anesthetized with vaporized 2.5% isofluorane balanced with pure oxygen delivered through a nose cone during the surgical placement of arterial and venous catheters: right jugular catheter (MRE, 0.035 mm ID and 0.084 mm OD, Braintree Scientific, Braintree, MA, USA) was advanced towards the atrium for 18 FDG injection and the tail artery (PE-50, 0.58 mm I.D., and 0.965 mm O.D. Stoelting Co. Wood Dale, IL, USA) was cannulated for blood sampling during the PET imaging period. 30 Rats were then transported to the Inveon PET (Siemens, Knoxville, TN, USA) bed and maintained with a mixture of vaporized isofluorane, pure oxygen, and room air. Anesthesia level (1% to 2%), oxygen flow rate (0.05 to 0.2 liters per minute) and air flow rate (0.5 to 0.6 liters per minute) were adjusted to achieve a consistent physiologic status across animals. Absence of hind leg pinch reflex was monitored throughout the PET scan to ensure depth of anesthesia. Heart rate, respiratory rate (breaths/min), plethysmography, and oxygen saturation (%) were monitored (via hind leg sensor) and recorded throughout the experiment using a pulse oximeter system (MouseOx, Starr life sciences, Oakmont, PA, USA) ( Table 1) . To maintain breath rates (B70 per minute) and normal blood gases throughout the 1.5-hour imaging process, isofluorane was adjusted, as well as the oxygen percentage and flow rates.
Physiological Parameters
Plasma glucose, lactate, and total ketone bodies (BHB þ acetoacetate) concentrations were measured pre-and post imaging (t ¼ 0, 60 minutes) from a blood sample collected (0.1 mL) from the tail artery catheter. The whole blood samples were centrifuged and the plasma separated and immediately frozen in dry ice; the end-of-imaging hematocrits were also recorded. Plasma D-glucose and L-lactate were later measured by YSI 2700 Biochemistry Analyzer (YSI, Yellow Springs, OH, USA) and the plasma total ketone bodies were measured by gas chromatography-mass spectrometry, as previously described. 31 Arterial blood gas parameters (pH, P aO2, and P aCO2 ) were measured at t ¼ 0, 45 minutes (ABL5 Radiometer, Copenhagen, Denmark); 45 minutes was considered the end point where CMR glc reached steady state. 32, 33 Arterial blood glucose was measured at t ¼ 15, 30, and 45 minutes to verify the steady-state plasma glucose concentration during the experiment (Precision Xtra Meter, Abbott Diabetes Care Inc., Alameda, CA, USA). The breath and heart rates were also recorded throughout the imaging process and were used as indicators for physiologic status.
Image Acquisition and Blood Sampling
A dual-modal PET-CT device, Inveon (Siemens), was used to image the 18 FDG activities in the brain. The rats' eyes were placed at the center of the field of view for the best spatial resolution. First, a 10-minute transmission scan was performed before the 18 FDG tracer injection. The transmission scan generates tissue attenuation map for attenuation correction in the PET images. Then 10±2 Mbq/100 g of 18 FDG was injected through the jugular line at time 0. Simultaneously, a 60-minute listmode PET emission scan was started along with the automatic arterial sampling using a customized blood acquisition module. The blood acquisition module device acquires the whole blood radioactivity in the first 2.5 minutes post injection, at a rate of 0.2 mL/minute, specified by a connected syringe pump (Harvard Pump 11 plus, Holliston, MA, USA). The pump was stopped at 2.5 minutes post injection. Manual sampling for arterial blood activity was performed at 3.5, 5, 7.5, 10, 15, 25, 40, 50, 60 minutes, using heparin-coated, microcapillary tubes (HT9H, Statspin, Westwood, MA, USA) with each tube's volume no more than 9 mL. On the experimental day, the total blood sample volumes were noted from each rat, which was less than 1.4 mL.
After the PET emission scan, the manually sampled bloods were centrifuged (RH12, Statspin). The volume inside the microhematocrit tubes were premeasured as 8.3 mL/37 mm, therefore by measuring the length of the whole blood portion, whole blood activity per volume (C wb * ), was obtained by converting the counts from a Gamma counter (LKB1282 Compugamma, LKB Instruments, Mt Waverley, Vic, Australia) and time correct to time 0. Hematocrit tubes were then broken and the plasma radioactivity (C p * ) was also counted and corrected for the decay. The hematocrits at 3.5 (when manual sampling begins) and 60 minutes were recorded.
The first 2.5 minutes of input function C wb * , was converted to C p * by a factor R. This follows
wb ðt ¼ 3:5Þ The manually sampled plasma radioactivity data were time corrected to the 18 FDG injection time and the half-life (107 minutes). The blood acquisition module and manually sampled data were combined and saved in a text file for the Matlab (The MathWorks, Natick, MA, USA) program analysis. Factor R was not different between diet groups (1.7 ± 0.10 versus 1.6±0.10; STD, KG, respectively).
Image Processing: Region and Volumes of Interest
The list mode emission data were binned to 34 frames: 6 Â 10, 6 Â 20, 4 Â 30 seconds, 3 Â 1, 2 Â 2, 2 Â 4, and 5 Â 8 minutes. The reconstruction algorithm on the scanner was set to OSEM2D with a ramp filter supplied by the vendor of the scanner. The final images were saved as coronal, transversal, and sagittal images with 128 Â 128 pixels, and the resolution was 0.78 mm in the sagittal, transversal sections and 0.79 mm in the coronal section. The value of each voxel in the reconstructed PET image sets is converted to radioactivity per volume. 
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The processed PET radioactivity image data were analyzed using Carimas 2 (Turku PET centre,Turku, Finland), to generate the region of interest (ROI) and volume of interest (VOI) data. Both the left and right eyes were identified as the landmarks. A rat brain atlas (Paxinos and Watson, Academic Press) was used to guide the selection of the region of interest and VOI. Starting from the rear of the eyecup, with slice thickness 0.125 mm, the left and right entire cortical hemispheres were encircled and two separate VOIs were generated. Similarly, the whole volumetric cerebellum was selected as one VOI. A separate PET CT image set for a rat of the same range (P60 to P80) of age was overlaid to verify the cortical and cerebellar regions (see Supplementary Material 4) . The two hemispheres, VOI and the cerebellum VOI, were saved to text files and made importable to the Matlab program as the time activity curve format.
Parameter Estimation and Calculation of CMR glc
We developed a MatLab program to perform the parameter estimation and calculation of CMR glc . The plasma input function was interpolated to render a time resolution of 0.1 second. Then the 34-frame time activity curve was matched with the input function for each of the time points. The Gjedde-Patlak plots were generated and only the last six matching points, namely the time after 25 minutes data were used to generate the parameter K i , which follows:
While k 1 * is the 18 FDG transport rate constant (/minute) to the brain tissue, k 2 * is the 18 FDG reverse transport rate constant from tissue to the plasma (/minute) and k 3 * is the 18 FDG phosphorylation rate constant (/minute).
The lumped constant in both the KG-and the STD-diet rats were assumed to be 0.71. 34 . The 60-minute plasma glucose level, C p , was used to generate the final CMR glc , which follows:
RESULTS
Physiologic Parameters
There were no significant differences in body weights, blood gases, physiologic parameters, and plasma glucose concentrations between KG-and STD-diet groups after 3 weeks of feeding the diets ( Table 1) . As expected, plasma ketone (BHB, acetoacetate) concentrations were statistically higher and the plasma lactate concentrations were lower in the KG rats compared with the STD group. 29 Ketosis ranged between 0.4 to 6.2 mmol/L as measured by total plasma ketone bodies ( Figure 1) ; the STD group was mildly ketotic (0.3 to 0.9 mmol/L, plasma total ketone bodies) after a 6-hour fast before imaging. Lactate concentrations in the plasma were significantly lower in the KG-diet group (0.77±0.18 mmol/L), Table 1 .
Cerebral Glucose Metabolic Rates
The averages of the CMR glc (mmol/100 g per minute) measured in both the cerebral hemispheres and cerebellum are shown in Table 2 . There were no significant differences in CMR glc between the left and right hemispheres. The PET analysis revealed that dietinduced ketosis resulted in a significant decrease in the average CMR glc in both the cerebral hemispheres and cerebellum compared with STD group. Cerebral metabolic rates of glucose was significantly lower in the left and right cerebral hemispheres compared with the cerebellum, in both dietary groups.
The CMR glc calculated with Gjedde-Patlak analysis was plotted as a function of the measured total plasma ketone body concentrations (BHB þ acetoacetate; mmol/L) (Figure 1 ). These data showed that the cerebral (left and right hemispheres) and cerebellar CMR glc decreased with increasing ketosis. The calculated CMR glc in each region was represented by a linear decrease with increasing total plasma ketone concentrations. There were no significant differences between the left and right cerebral hemispheres, (CMR glcright ¼ À2.9 Â (BHB þ AcAc) þ 34.9; R 2 ¼ 0.59); where as the cerebellar region was significantly higher (CMR glc ¼ À3.7 Â (BHB þ AcAc) þ 43.9; R 2 ¼ 0.59) compared with and plotted as a function of the measured plasma total ketone body concentrations; the equation CMR glc ¼ (slope Â plasma total ketone concentrations þ CMR glc at non-ketogenic state) corresponds to the linear correlation; 'goodness of fit' was represented as the coefficient of determination, R 2 , which reflected B0.61 for each VOI. The STD diet group (n ¼ 9) total plasma ketone bodies were less than 0.87 mmol/L and the KG diet group (n ¼ 10) was greater than 3.0 mmol/L. These results demonstrate that CMR glc decreased B9% for each 1 mmol/L increase in total plasma ketone body concentration in ketotic rats induced by 3 weeks of KG diet. cerebral cortex. These data highlight the proportional change in CMR glc with increasing ketosis; thus for every 1 mmol/L increase in total plasma ketone bodies, CMR glc decreases by B9%.
Meta-analysis of CMR glc in Ketotic Subjects
Meta-analysis of CMR glc reduction in ketotic subjects (human or rats) was shown in Figure 2 . All data were collected from previously reported studies where CMR glc was measured and level of ketosis was reported. In each reported study, the CMR glc data from the ketotic subjects were normalized to the non-ketotic controls (%) and then graphed against the total blood ketone body concentrations (mmol/L). The normalization eliminated inconsistencies across studies due to anesthesia effects and species differences. The normalized glucose utilization rate decreased B9% for each 1 mmol/L increase of the total blood ketone bodies. A summary of these data collected from the various studies measuring CMR glc and blood ketone concentrations include (see Figure 2 legend for details): PET-FDG studies conducted in fasted humans showing a 27% decrease in CMR glc after 3.5 days of fasting, 7 in humans that were fasted for 3 weeks, the authors reported a 46% decrease in CMR glc relative to the nonfasted baseline conditions. 2 Other studies using different methodologies for assessing glucose utilization in ketotic rats also showed similar decreases. In one study where [6- 14 C]glucose and autoradiography were applied, glucose utilization decreased 12% in conscious 2-day fasted rats with mild ketosis. 6 
DISCUSSION
We report here, in diet-induced ketotic rats, decreases in CMR glc highly correlate with both the level and the duration of the ketosis. These data revealed that the degree and duration of ketosis have a major role in determining corresponding changes in CMR glc with ketosis. We also present a retrospective analysis of historical data (meta-analysis) that appears to reconcile the inconsistencies from previous studies, which supports our conclusion. The brain's ability to switch from glucose oxidation towards ketone bodies requires a type of 'cerebral metabolic adaptation'. This process is not well understood but is thought to be highly associated with the duration and level of ketosis. 10, 19, 37, 38 Ketones are considered to supply up to 70% of the total energy demands once maximal metabolic adaptation occurs. 1 Blood ketones become elevated during prolonged fasting or with a ketogenic diet reaching a state ketosis and glucose sparing. During this process, monocaboxylic transporters upregulate at the blood-brain barrier with increasing demand for ketone utilization by brain. 37, 38 Recently, investigators have recognized additional therapeutic properties of ketosis, such as neuroprotection after stroke or injury. 19, 20 What remains unclear is whether the neuroprotective or therapeutic properties of ketosis is as a result of changes in the regulation of metabolic signaling pathways. These would include those associated with enzyme-catalyzed steps involved with glucose regulation 39 or glucose independent pathways, such as the Nrf2 pathway (a responder to cellular stress). 17 In this study, we questioned whether cerebral metabolism of ketone bodies (CMR ket ) replaces CMR glc after 3 weeks of diet-induced ketosis.
Previous studies measuring CMR glc in ketotic subjects report either changes in CMR glc with ketosis or failure to detect significant changes. [1] [2] [3] [5] [6] [7] 21, 22, 27, 28 Historically, it has been established that brain can utilize ketone bodies under ketotic conditions. 1, 4, 10, [13] [14] [15] [16] 39 However, corresponding changes in CMR glc during 'metabolic adaptation' to ketosis has not been clearly described. Using PET-FDG imaging, the focus of this study was to determine if CMR glc decreases with increasing ketosis in adultanesthetized diet-induced ketotic rats. CMR glc in the cerebral hemispheres and cerebellum decreased with increasing ketosis (0.3 to 6.3 mmol/L) in rats fed either STD or KG diets for 3 weeks. These data are consistent with the conclusions described in the classic human study by Owen et al. 1 Their study was the first to highlight that the brain can switch from glucose oxidation to ketone body oxidation with chronic ketosis. Most revealing to us was a previous study using a similar rat model of diet-induced ketosis to measure changes CMR glc . 21 The study failed to detect significant changes in CMR glc even though the duration and method of induction of ketosis was similar. However, the level of ketosis was four-fold lower making it difficult to detect a corresponding change in CMR glc with ketosis.
The most striking information obtained from our study was the correlative finding that CMR glc decreased 9% with every 1 mmol/L increase in total plasma ketones. Although not previously reported as such, the results of this study are consistent with previous studies measuring CMR glc in ketotic subjects, as our meta-analysis (Figure 2 ) also showed the same linear association between level of ketosis and corresponding changes in CMR glc . The metaanalysis supports our current findings and has brought new insight into previous studies (as authors' interpretations led to discrepancies or incomplete conclusions). One explanation for the discrepancies may be the difficulty to distinguish small changes in CMR glc with a small degree of ketosis. This was the case with our previous study in diet-induced ketotic rats where CMR glc was assessed using 2-DG. 21 The level of ketosis was less than 1 mmol/L, making it difficult to detect a less than 9% decrease in glucose utilization using a non-imaging compartment modeling method.
Another consideration is the induction of ketosis through acute ketone body infusions. The main difficulty to this approach is the lack Figure 2 . Meta-analysis of cerebral metabolic rate for glucose (CMR glc ) reduction in ketotic subjects (human or rats). All data were collected from previously reported studies where CMR glc was measured and level of ketosis was reported. Data were normalized (%) against control state (non-fasted, non-diabetic conditions) and graphed as a function of total blood ketone bodies level (mmol/L). The study, method, and reported outcome is noted for each point: (a) data from Al-Mudallal et al, 21 ketosis by KG diet in rat, 2-DG method; no significant cortical change in CMR glc , (b) data from Corddry et al, 22 3 days fasted rats, 2-DG method; frontal cortical change, not significant, (c) and (d) data from Dalquist et al, 27 3 days fasted rats, A-V uptake method; no significant change, (e) data from Hasselbach et al, 5 3.5 days fasted humans, PET-FDG imaging; significant reduction, (f ) data from Owen et al, 1 5 to 6 weeks fasted obese human subjects, A-V uptake method, CMR glc , was indirectly calculated by O 2 consumption; significant change, (g) data from Redies et al, 2 20 to 24 days fasted obese human subjects, PET-FDG and A-V uptake method; significant CMR glc reduction, (h) data from Ruderman et al, 7 1-2 days fasted rats, A-V uptake method; trended significant, (i) Data from Mans et al, 6 2 days fasted rats, compartmental modeling with non-trapping tracer (autoradiography); significant reduction, (j) data from Issad et al, 28 2 days fasted rats, (autoradiography), no significant change, (k) data from Cherel et al, 3 6 days fasted rats, modified 2-DG method, no significant change. The meta-analysis plot shows a linear relationship between CMR glc and level of ketosis in human or rat subjects. For each 1 mmol/L of total blood ketone concentration increase, there was approximately a 9% decrease in CMR glc .
of metabolic adaptation to ketosis. 29, 38 We have previously shown metabolic adaptation to ketosis is directly associated with duration of ketosis and level of ketosis. 18, 29 Thus, in some studies using acute infusions of ketones to mimic ketotic conditions, the outcome failed to show decreases (or consistency) in glucose utilization. 25 An exception might be in studies where low doses were given after short-term fasting, but the analytical approach often requires a higher degree of sensitivity for detecting small changes in CMR glc . 40 Variabilities in experimental models such as, physiologic status, level of ketosis via metabolic adaptation, and analytical approach have a key role in the measured outcome. The emphasis of our current study was to use PET imaging together with our diet-induced rat model of ketosis to measure detectable changes in CMR glc .
In summary, CMR glc decreased B9% in both the cortex and the cerebellum for each 1 mmol/L increase in blood ketone bodies, which is consistent with diet-induced ketosis, as well as long-and short-term fasted ketosis. We attribute previous discrepancies to (1) the failure to detect significant differences within and across studies, (2) inadequate metabolic adaptation to ketosis, and (3) difficulty in establishing and/or maintaining a higher degree of ketosis. Our work puts historical data into a current perspective by reconciling the inconsistencies from previous studies where little or no change in CMR glc with ketosis was reported. Nevertheless, the maximum percent ketone bodies that can replace glucose oxidation still need to be determined. A quantitative understanding of CMR glc and CMR ket under different durations and degrees of ketosis would elucidate the energy balance between glucose and ketone bodies.
